直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

$1.54 Billion Damages Award Vacated: Were Goods That Never Entered U.S. “Sold” Domestically?

August 06, 2015

Authored and Edited by Elizabeth D. Ferrill; Yieyie Yang, Ph.D.

In Carnegie Mellon University v. Marvell Technology Group, No. 2014-1492 (Fed. Cir. Aug. 4, 2015), the Federal Circuit vacated the largest damages judgment in history for patent infringement—$1.54 billion. It concluded that accused chips not made in, or imported into, the United States may nevertheless be included in the damages analysis if the United States is the location of “sale.” But, the Court remanded the case for the district court to determine whether the chips were sold in the United States.

The Court stressed that § 271(a) clearly defined the extraterritorial reach of patent infringement damages—“making or using or selling in the United States or importing into the United States, even if one of more of those activities also occur abroad.”  Accordingly, the Court concluded that where a physical product is used to measure damages for the infringement of method patents, “territoriality is satisfied when and only when any one of those domestic actions for that unit (e.g., sale) is proved to be present, even if others of the listed activities for that unit (e.g., making, using) take place abroad.” For Marvell’s chips that were not made, used, or imported into the United States, the Court held that the chips needed to be sold domestically to be used in measuring the royalty, and that question required a remand.

Tags

damages, remedies

Contacts

Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Reception

2026 IPO Education Foundation Awards Dinner

December 15, 2026

Washington, DC

Conference

IAM Live: Navigating the UPC 2026

November 4, 2026

Paris

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Lecture

2026 Donald R. Dunner Endowed Lecture

October 27, 2026

Washington, DC

Seminar

Future IP UK

October 21, 2026

London

Conference

ChIPs Global Summit 2026

October 21-23, 2026

Los Angeles

Conference

31st Annual UMass Chan Research Retreat

October 14-15, 2026

Worcester

Conference

2026 FCBA Global Series Fall Session

October 14-16, 2026

Dublin

Conference

WTR Live: Brand Strategy Summit USA 2026

October 13-14, 2026

New York

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP